Safety and Anti-Disease Activity of Oral Tosedostat (CHR-2797) in Elderly Subjects With Refractory or Relapsed AML; OPAL

Press/Media

Period2 Oct 2018

Media coverage

1

Media coverage

  • TitleSafety and Anti-Disease Activity of Oral Tosedostat (CHR-2797) in Elderly Subjects With Refractory or Relapsed AML; OPAL
    Media name/outletClinical Trials.gov
    Country/TerritoryUnited States
    Date2/10/18
    PersonsSamir Parekh
View all 1
View less